Kirsten L. Bryant, PhD
Assistant Professor, Department of Pharmacology
About
Kirsten L. Bryant, PhD, is a UNC Lineberger research member studying the relatively unexplored mechanisms by which the KRAS oncogene drives the altered metabolic processes that fuel pancreatic cancer growth. Her research is focused on the metabolic activity, autophagy, and further advancing autophagy inhibition as a therapeutic approach.
UNC Lineberger Research Member
Cancer Cell Biology Research ProgramNews and Stories
-
Hirshberg Foundation backs Bryant Lab to investigate metabolic adaptations to RAS inhibition in pancreatic cancer
Kirsten Bryant, PhD, has been awarded a $100,000 seed grant for her project that seeks to define and target metabolic changes associated with RAS inhibition in pancreatic ductal adenocarcinoma.
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.